M. T. Barbosa

Altered behavioral and metabolic circadian rhythms in mice with disrupted NAD+ oscillation

P. Sassone-Corsi, S. Sahar, E. Chini, 2011, Aging.

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38

D. Sinclair, T. White, E. Chini, 2013, Diabetes.

The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet‐induced obesity

J. Levine, D. Sinclair, C. Novak, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome. Diabetes 2013;62:1084–1093

D. Sinclair, T. White, E. Chini, 2014, Diabetes.

Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors

E. Chini, Claudia C. S. Chini, Juliana Camacho-Pereira, 2013, Clinical Cancer Research.

Reducing Door-to-Reperfusion Time for Mechanical Thrombectomy With a Multitiered Notification System for Acute Ischemic Stroke

William W. Horn, S. Silvers, W. Freeman, 2018, Mayo Clinic proceedings. Innovations, quality & outcomes.

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome. Diabetes 2013;62:1084–1093

D. Sinclair, T. White, E. Chini, 2014, Diabetes.

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38

D. Sinclair, T. White, E. Chini, 2013, Diabetes.